In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.
Nicosia D., Federico A., Vigna I., Iozzo P., Misseri G., & Cortegiani A. (2019). Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy. CLINICAL CASE REPORTS, 7(4), 665-667 [10.1002/ccr3.2061].
Data di pubblicazione: | 2019 | |
Titolo: | Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy | |
Autori: | Cortegiani, Andrea (Corresponding) | |
Citazione: | Nicosia D., Federico A., Vigna I., Iozzo P., Misseri G., & Cortegiani A. (2019). Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy. CLINICAL CASE REPORTS, 7(4), 665-667 [10.1002/ccr3.2061]. | |
Rivista: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.1002/ccr3.2061 | |
Abstract: | In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed. | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
ccr3.2061.pdf | Versione Editoriale | Open Access Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.